Evidence map›Paper›PMID 37611070›Full record

ArticlePLoS pathogens2023

Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection.

Quynh T Phan, Norma V Solis, Max V Cravener, Marc Swidergall, Jianfeng Lin, Manning Y Huang, Hong Liu, Shakti Singh, Ashraf S Ibrahim, Massimiliano Mazzone and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Gut microbes · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. mBio · 2026
    Article
  6. Review
  7. Gut microbes · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Host targets of candidalysin.PLoS pathogens · 2025
    Review
  12. Evaluating the Role ofInterdisciplinary perspectives on infectious diseases · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Epithelial responses to fungal pathogens.Current opinion in microbiology · 2024
    Review
  17. Microbiology and molecular biology reviews : MMBR · 2024
    Review
4 · The record

Corrections and comments

  • Update of
    2023
5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Quynh T PhanInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Norma V SolisInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Max V CravenerDepartment of Microbiology, University of Georgia, Athens, Georgia United States of America.
Marc SwidergallInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Jianfeng LinInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Manning Y HuangDepartment of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.
Hong LiuInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Shakti SinghInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Ashraf S IbrahimInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Massimiliano MazzoneLaboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.
Aaron P MitchellDepartment of Microbiology, University of Georgia, Athens, Georgia United States of America.
Scott G FillerInstitute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.ORCID 0000-0001-7278-3700
UCLA Medical Center · USUniversity of California, Los Angeles · USUniversity of Georgia · USUniversity of California, San Francisco · USVIB-KU Leuven Center for Cancer Biology · BE

Funding

C. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0M
Oral commensal fungi and structural immunityR01DE031382 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI Marc Swidergall · 2022 to 2026
$2.5M
NIDCR NIH HHS R01 DE026600NIDCR NIH HHS R01 DE031382
6 · The paper itself

Abstract

Fungal invasion of the oral epithelium is central to the pathogenesis of oropharyngeal candidiasis (OPC). Candida albicans invades the oral epithelium by receptor-induced endocytosis but this process is incompletely understood. We found that C. albicans infection of oral epithelial cells induces c-Met to form a multi-protein complex with E-cadherin and the epidermal growth factor receptor (EGFR). E-cadherin is necessary for C. albicans to activate both c-Met and EGFR and to induce the endocytosis of C. albicans. Proteomics analysis revealed that c-Met interacts with C. albicans Hyr1, Als3 and Ssa1. Both Hyr1 and Als3 are required for C. albicans to stimulate c-Met and EGFR in oral epithelial cells in vitro and for full virulence during OPC in mice. Treating mice with small molecule inhibitors of c-Met and EGFR ameliorates OPC, demonstrating the potential therapeutic efficacy of blocking these host receptors for C. albicans.

Indexed as

Candida albicansCandidiasis, OralAmyotrophic Lateral SclerosisAnimalsCadherinsCell MembraneEpithelial CellsErbB ReceptorsMiceCadherinsErbB Receptors

Identifiers

PMID37611070
PMCPMC10479894
OpenAlexW4386086248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.